期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (1)
Purpose The purposes of this study were to evaluate the current situation of pain management outcomes, patients' pain knowledge, and family caregivers......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (4)
Purpose While the existing knowledge base on the impact of prostate cancer (PC) and its treatment on sexuality and intimacy has been generated from We......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (5)
Purpose To determine the effect of various cleaning methods for skin with acute radiation dermatitis (RD) in patients treated for nasopharyngeal carci......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (5)
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of anticancer treatment based on neurotoxic agents, which may affect......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (7)
Objective A prospective randomized controlled trial was conducted to compare 5 mg olanzapine plus standard triple antiemetic therapy for the preventio......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (10)
Background and objectives The purpose of this study is to determine the risk of constipation and to identify the significant risk factors for constipa......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (3)
Objective Decreased quality of life (QoL) in thyroid cancer patients after thyroidectomy is a common, but there is a lack of predictive methods for de......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (10)
Purpose To quantify financial toxicity of female patients with breast cancer in China and investigate its factors and patients' coping strategies. Met......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (11)
Purpose The elevated physical symptom burden in advanced lung cancer can disrupt patients' emotional well-being, and current literature suggests that ......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (11)
Purpose Heated humidified high-flow nasal cannula (HFNC) oxygen therapy is one of the most important oxygen therapy methods, which are commonly applie......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (1)
Background Few mortality-scoring models are available for solid tumor patients who are predisposed to develop Escherichia coli-caused bloodstream infe......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (2)
Background Sarcopenia has been proved to be related to the prognosis of patients with bladder cancer (BC) after radical cystectomy (RC). The relations......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (5)
Background Obesity and weight gain have been associated with poor disease-specific and health-related outcomes in breast cancer survivors (BCS). But t......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (6)
Purpose The aim of this study was to investigate symptom clusters and associated clinical factors in ambulatory multiple myeloma patients undergoing m......
期刊: SUPPORTIVE CARE IN CANCER, 2022; 30 (7)
Purpose Axicabtagene ciloleucel (Axi-Cel, 2 x 10(6) CAR-T cells/kg, single intravenous injection) is a chimeric antigen receptor cell immunotherapy th......